• Yali Wei, Chen Jiang, Yiping Han, Wen Song, Xiaoyu Li, and Xiaoyan Yin.
• Department of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.
• Medicine (Baltimore). 2022 Dec 2; 101 (48): e31968e31968.

AbstractHelicobacter pylori (H pylori) eradication treatment can reduce the risk of gastric cancer. However, early gastric cancer (EGC) can still be detected after eradication. Meanwhile, EGC after eradication is challenging to diagnose by an endoscopist in some cases due to the lack of apparent characteristics and the complex mucosal status. This review aims to summarize the endoscopic and histological characteristics and the mucosal risk factors for gastric cancer after H pylori eradication. The literature was searched for possible reported gastric cancer after eradication in "PubMed." These included related clinical studies and reviews, and unrelated or non-English articles were excluded. Endoscopically, EGC displays a small, reddish and depressed lesion, indistinct border, "gastritis-like" appearance and submucosal invasion. Histologically, it is divided into surface differentiation, nontumorous epithelium, and intestinal type. The risk factors include severe gastric atrophy, intestinal metaplasia in the corpus, and map-like redness. In conclusion, these studies on the characteristics and risk mucosal factors of patients with gastric cancer after H pylori eradication will drive the establishment of a novel endoscopic surveillance and diagnosis system for H pylori-eradicated patients.Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

3 keywords...

hide…